Workflow
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
AGIOAgios Pharmaceuticals(AGIO) Newsfilter·2025-03-06 06:52